U.S. Markets closed

Should You Go for the 'Easy Money' in Novartis?

Should You Go for the 'Easy Money' in Novartis?

Jim Cramer has a number of investing rules and Rule No. 1 is always go for the easy money, not the hard money. Sometimes companies transition from easy-money stocks to hard-money stocks, Cramer explained, and being able to spot the difference is crucial. The easy money in pharma is Novartis AG so let's check out the charts and indicators.